Zhen Ruan

State Key Laboratory Of Quality Research In Chinese Medicine
Macao, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Consolidating International Care Models and Clinical Services for Adult Obesity.

Consolidating International Care Models and Clinical Services for Adult Obesity.

Journal: Current obesity reports

Published: March 18, 2025

Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature.

Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature.

Journal: Frontiers in endocrinology

Published: July 07, 2023

Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review.

Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review.

Journal: Expert review of clinical pharmacology

Published: January 27, 2023

Policy analysis of system responses to addressing and reversing the obesity trend in China: a documentary research.

Policy analysis of system responses to addressing and reversing the obesity trend in China: a documentary research.

Journal: BMC public health

Published: January 16, 2023

Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials.

Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials.

Journal: Expert review of clinical pharmacology

Published: September 30, 2022

Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China.

Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: September 28, 2022

Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China.

Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: May 29, 2022

Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review.

Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: February 14, 2022

Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review.

Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review.

Journal: Frontiers in public health

Published: August 28, 2021

The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review.

The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: December 15, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026